TrialAnnals of the rheumatic diseases2011

Canakinumab reduces the risk of acute gouty arthritis flares during initiation of allopurinol treatment: results of a double-blind, randomised study.

Naomi Schlesinger et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.